Large scale gene expression analysis of osteoclastogenesis in vitro and elucidation of NFAT2 as a key regulator
- PMID: 12171919
- DOI: 10.1074/jbc.M205063200
Large scale gene expression analysis of osteoclastogenesis in vitro and elucidation of NFAT2 as a key regulator
Abstract
To understand the molecular events coupling between cell proliferation and differentiation by elucidating genes essential for the process, we conducted a large scale gene expression analysis of an in vitro osteoclastogenesis system consisting of recombinant RANKL and mouse RAW264 cells. The entire process leading to the formation of tartrate resistant acid phosphatase-positive multinucleated cells takes 3 days and plates become fully covered with multinucleated cells at 4 days. Microarray probing at eight time points revealed 635 genes that showed greater than 2-fold differential expression for at least one time point and they could be classified into six groups by the "k-means" clustering analysis. Among a group of 106 early inducible genes (within 2-5 h after RANKL stimulation), four genes including NFAT2 were identified as genes whose enhanced expressions were fairly correlated with an efficient induction of matured osteoclasts. Moreover, cyclosporin A significantly suppressed the multinucleated cell formation accompanying the reduction of the nuclear localization of NFAT2. When the expression of NFAT2 was suppressed by introducing antisense NFAT2, multinucleated cell formation was severely hampered. Functional analysis thus combined with gene analysis by microarray technology elucidated a key role of NFAT2 in osteoclastogenesis in vitro.
Similar articles
-
Critical roles of c-Jun signaling in regulation of NFAT family and RANKL-regulated osteoclast differentiation.J Clin Invest. 2004 Aug;114(4):475-84. doi: 10.1172/JCI19657. J Clin Invest. 2004. PMID: 15314684 Free PMC article.
-
CCR1 acts downstream of NFAT2 in osteoclastogenesis and enhances cell migration.J Bone Miner Res. 2006 Jan;21(1):48-57. doi: 10.1359/JBMR.051001. Epub 2005 Oct 10. J Bone Miner Res. 2006. PMID: 16355273
-
A novel role of L-serine (L-Ser) for the expression of nuclear factor of activated T cells (NFAT)2 in receptor activator of nuclear factor kappa B ligand (RANKL)-induced osteoclastogenesis in vitro.J Bone Miner Metab. 2006;24(5):373-9. doi: 10.1007/s00774-006-0705-0. J Bone Miner Metab. 2006. PMID: 16937269
-
Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts.Dev Cell. 2002 Dec;3(6):889-901. doi: 10.1016/s1534-5807(02)00369-6. Dev Cell. 2002. PMID: 12479813
-
[GeneChip analysis for osteoimmunology].Nihon Rinsho Meneki Gakkai Kaishi. 2005 Apr;28(2):79-85. doi: 10.2177/jsci.28.79. Nihon Rinsho Meneki Gakkai Kaishi. 2005. PMID: 15863966 Review. Japanese.
Cited by
-
Fisetin Inhibits Osteoclast Differentiation via Downregulation of p38 and c-Fos-NFATc1 Signaling Pathways.Evid Based Complement Alternat Med. 2012;2012:810563. doi: 10.1155/2012/810563. Epub 2012 Sep 12. Evid Based Complement Alternat Med. 2012. PMID: 23008743 Free PMC article.
-
Calcineurin/NFAT signalling inhibits myeloid haematopoiesis.EMBO Mol Med. 2012 Apr;4(4):269-82. doi: 10.1002/emmm.201100207. Epub 2012 Feb 7. EMBO Mol Med. 2012. PMID: 22311511 Free PMC article.
-
Effects of Type 2 Diabetes Mellitus on Osteoclast Differentiation, Activity, and Cortical Bone Formation in POSTmenopausal MRONJ Patients.J Clin Med. 2022 Apr 23;11(9):2377. doi: 10.3390/jcm11092377. J Clin Med. 2022. PMID: 35566506 Free PMC article.
-
The RING domain and first zinc finger of TRAF6 coordinate signaling by interleukin-1, lipopolysaccharide, and RANKL.J Biol Chem. 2008 Sep 5;283(36):24871-80. doi: 10.1074/jbc.M802749200. Epub 2008 Jul 10. J Biol Chem. 2008. PMID: 18617513 Free PMC article.
-
Pregnenolone Inhibits Osteoclast Differentiation and Protects Against Lipopolysaccharide-Induced Inflammatory Bone Destruction and Ovariectomy-Induced Bone Loss.Front Pharmacol. 2020 Mar 27;11:360. doi: 10.3389/fphar.2020.00360. eCollection 2020. Front Pharmacol. 2020. PMID: 32292342 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous